- Presentations
- 2
- Markets
- 1
Idhifa is a brand of Enasidenib marketed by Celgene, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Enasidenib
- Brand owner
- Celgene
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 50 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Idhifa 100 mg tabletOral | Celgene | US FDA | Available on request |
| Idhifa 50 mg tabletOral | Celgene | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Idhifa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.